Physic Ventures

Physic Ventures targets early-stage consumer companies that commercialize scientific research in health, wellness, and sustainability. The firm invests at Seed and Series A stages, seeking founders who translate peer-reviewed science into scalable, direct-to-consumer products. Its portfolio concentrates on digital health, food-tech, and health-adjacent fintech.

Known portfolio companies include LumiHealth, a digital therapeutic platform; Olly Nutrition, a wellness brand acquired by Unilever; and personalized nutrition company Habit, later acquired by Viome. These investments reflect the firm's focus on science-backed consumer goods and digitally delivered health interventions.

No. Physic Ventures does not invest in FDA-regulated therapeutic biotech nor enterprise healthcare SaaS lacking a consumer endpoint. The firm explicitly seeks companies where scientific validation translates into products individuals can purchase and use directly, such as diagnostics, nutritional supplements, or wellness apps.

Physic Ventures is headquartered in San Francisco, California. Its primary investment geography is North America, though it has selectively considered European health-tech startups that demonstrate a clear regulatory pathway into US consumer markets.

Physic Ventures has not broadly publicized its full partnership structure or named a public-facing chief investment officer. Investment decisions appear to be made by its lean, thematic investment team operating from San Francisco, but specific named principals are not currently in the public record.